Indivior PLC (NASDAQ:INDV) reported that it has entered into a $175 million accelerated share repurchase (ASR) agreement with Barclays Bank PLC, prompting a 4.6% increase in the company's shares on Monday.
The firm said the ASR will be completed under its standing $400 million share repurchase program, which was previously approved by the company's Board of Directors. Management framed the transaction as a demonstration of confidence in Indivior's long-term plan, its ability to generate cash flow, and its approach to disciplined capital allocation.
Under the terms of the agreement, Indivior will pay Barclays $175 million up front. The company expects to receive an initial delivery of 3,717,473 shares shortly after the agreement is executed. The ultimate number of shares repurchased will be calculated using the volume weighted average price of Indivior's common stock over the ASR term, less a discount.
Indivior indicated that final settlement of the ASR is expected to occur no later than the end of June 2026. The company also stated it does not expect the ASR to affect its previously issued financial guidance.
In addition to the $175 million ASR, Indivior noted that $100 million remaining under the share repurchase authorization may be deployed for further repurchases from time to time. Such repurchases would depend on market conditions and other factors, and could be executed through open market trades, privately negotiated deals, or other legally permitted mechanisms.
Market and corporate finance context
The agreement highlights a use of balance sheet capacity under an existing repurchase authorization. By structuring the transaction as an ASR, Indivior secures immediate capital deployment while leaving the final share count subject to market pricing during the ASR period.
What remains subject to change
- The final number of shares retired through the ASR will vary with the volume weighted average price during the term.
- Timing of the ultimate settlement is set no later than the end of June 2026, leaving execution exposed to market dynamics over the ASR period.
- Any additional repurchases using the remaining $100 million authorization will be contingent on market conditions and other factors.